Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04572711 · ClinicalTrials.gov registry record
Prospective Evaluation of Biliary Tissue Sampling With ERCP
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 327
- Enrollment target
NCT04572711: Completed study, sponsored by Mayo Clinic.
NCT04572711 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 327 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04572711 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 327 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety, outcomes and performance characteristics of multiple biliary sampling techniques including but not limited to: single operator cholangioscopy (SOC) directed biopsies, transpapillary biliary biopsies (TPBx), brushings and bile aspiration for cytology and FISH in patients undergoing ERCP.
Primary Outcome
Accuracy, Sensitivity, Specificity for the detection of malignancy with each sampling technique. Accuracy was calculated as \[(true positives + true negatives)/ (true positives + true negatives + false positives + false negatives)\] x100 and reported as a percentage. Sensitivity was calculated as \[true positive/(true positive + false negative)\] x100 and reported as a percentage. Specificity was calculated as \[true negatives/(true negatives +false positives)\] x100 and reported as a percentage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2025-01-02 |
What the finished NCT04572711 record still lists
NCT04572711 is an observational study that tracks outcomes without assigning an intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04572711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04572711 about?
NCT04572711 is a clinical study titled "Prospective Evaluation of Biliary Tissue Sampling With ERCP". The purpose of this study is to assess the safety, outcomes and performance characteristics of multiple biliary sampling techniques including but not limited to: single operator cholangioscopy (SOC) directed biopsies, transpapillary biliary biopsies (TPBx), brushings and bile aspiration for cytology...
What is the current status of trial NCT04572711?
This trial is currently completed. The enrollment target is 327 participants. The study started on 2020-10-01. Estimated completion is 2025-01-02.
Who is sponsoring clinical trial NCT04572711?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- NCT06370182 · 327 participants · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI